Clinical Trial Update: Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing intravitreal bevacizumab alone versus bevacizumab plus triamcinolone for central retinal vein occlusion; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Retinovascular Disease | Phase 2 | Status: UNKNOWN